Contribution of Hyperinsulinemia vs. Hyperglycemia to Insulin Resistance in Type 1 Diabetes and Maturity Onset Diabetes of the Young, Type 2 (MODY2)

NCT02971202 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes Mellitus
Maturity-Onset Diabetes of the Young, Type 2
MODY2
Insulin Resistance

Interventions

DRUG: Hyperinsulinemic, euglycemic clamp
DRUG: 20% dextrose

Sponsor

Vanderbilt University